Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART101 for Immune Reconstitution in HSCT
NCT04959903Phase 2Recruiting
- Sponsor
- Smart Immune
- Start
- Mar 2022
- Primary completion
- Aug 2025
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of SMART101 in hematological malignancies, sponsored by Smart Immune. Started Mar 2022; status: recruiting.
02
Drugs
SMART101
03
Conditions
hematological malignancies
Beyond the preview
Go deeper on NCT04959903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04959903.